Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 10/09/20021 min de lecture
Withdrawal of Guidances on Estrogen and Estrogen/Progestin-Containing Drug Products
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing the withdrawal of two guidances: A draft entitled"Labeling Guidance for Noncontraceptive Estrogen Drug Products--Prescibing Information for Healthcare Providers and Patient Labeling" and a final "Guidance for Clinical Evaluation of Combination Estrogen/Progestin-Containing Drug Products Used for Hormone Replacement Therapy of Postmenopausal Women." These guidances are under agency review for change.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →